Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial-Reference-Cited by-同舟云学术

Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial

Author:

Höglinger Günter U.¹²³,Huppertz Hans-Jürgen⁴,Wagenpfeil Stefan⁵,Andrés María V⁶,Belloch Vincente⁷,León Teresa⁶,del Ser Teodoro⁸,

Affiliation:

1. Department of Neurology; Philipps Universität; Marburg Germany

2. Department of Neurology; Technische Universität München; Munich Germany

3. German Center for Neurodegenerative Diseases (DZNE); München Germany

4. Swiss Epilepsy Centre; Zürich Switzerland

5. Institute for Medical Biometry, Epidemiology and Medical Informatics (IMBEI); Universitätsklinikum des Saarlandes; Homburg/Saar Germany

6. Clinical Operations Department; Noscira SA; Madrid Spain

7. Scientific Department; Exploraciones Radiológicas Especiales (ERESA); Valencia Spain

8. Medical Department; Noscira SA; Madrid Spain

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference27 articles.

1. What are the bona fide GSK3 substrates [serial online]?;Sutherland;Int J Alzheimers Dis,2011

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献